Click for best price
Rare Biomarkers Specimen Collection And Stabilization Market Size, Share 2022
Rare biomarkers in disease management has driven investments toward clinical applications.
This report contains market size and forecasts of Rare Biomarkers Specimen Collection And Stabilization in Global, including the following market information:
The global Rare Biomarkers Specimen Collection And Stabilization market was valued at 29830 million in 2021 and is projected to reach US$ 50160 million by 2028, at a CAGR of 7.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Circulating Cell Free DNA (ccfDNA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rare Biomarkers Specimen Collection And Stabilization include Miltenyi Biotec, QIAGEN, Creatv MicroTech, Veridex, Creative-Bioarray, Genetix, STRECK, INC., Roche and Amgen. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rare Biomarkers Specimen Collection And Stabilization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rare Biomarkers Specimen Collection And Stabilization Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rare Biomarkers Specimen Collection And Stabilization Market Segment Percentages, by Type, 2021 (%)
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- Circulating Cell Free RNA (ccfRNA) / miRNA
Global Rare Biomarkers Specimen Collection And Stabilization Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rare Biomarkers Specimen Collection And Stabilization Market Segment Percentages, by Application, 2021 (%)
Global Rare Biomarkers Specimen Collection And Stabilization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rare Biomarkers Specimen Collection And Stabilization Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rare Biomarkers Specimen Collection And Stabilization revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Rare Biomarkers Specimen Collection And Stabilization revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Miltenyi Biotec
- QIAGEN
- Creatv MicroTech
- Veridex
- Creative-Bioarray
- Genetix
- STRECK, INC.
- Roche
- Amgen
| Report Attributes |
Report Details |
| Report Title |
Rare Biomarkers Specimen Collection And Stabilization Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rare Biomarkers Specimen Collection And Stabilization Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rare Biomarkers Specimen Collection And Stabilization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rare Biomarkers Specimen Collection And Stabilization Overall Market Size
2.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Size: 2021 VS 2028
2.2 Global Rare Biomarkers Specimen Collection And Stabilization Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rare Biomarkers Specimen Collection And Stabilization Players in Global Market
3.2 Top Global Rare Biomarkers Specimen Collection And Stabilization Companies Ranked by Revenue
3.3 Global Rare Biomarkers Specimen Collection And Stabilization Revenue by Companies
3.4 Top 3 and Top 5 Rare Biomarkers Specimen Collection And Stabilization Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rare Biomarkers Specimen Collection And Stabilization Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rare Biomarkers Specimen Collection And Stabilization Players in Global Market
3.6.1 List of Global Tier 1 Rare Biomarkers Specimen Collection And Stabilization Companies
3.6.2 List of Global Tier 2 and Tier 3 Rare Biomarkers Specimen Collection And Stabilization Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Rare Biomarkers Specimen Collection And Stabilization Market Size Markets, 2021 & 2028
4.1.2 Circulating Cell Free DNA (ccfDNA)
4.1.3 Circulating Tumor Cells (CTCs)
4.1.4 Exosomes/Extracellular Vesicles
4.1.5 Circulating Cell Free RNA (ccfRNA) / miRNA
4.2 By Type - Global Rare Biomarkers Specimen Collection And Stabilization Revenue & Forecasts
4.2.1 By Type - Global Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2022
4.2.2 By Type - Global Rare Biomarkers Specimen Collection And Stabilization Revenue, 2023-2028
4.2.3 By Type - Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rare Biomarkers Specimen Collection And Stabilization Market Size, 2021 & 2028
5.1.2 Research
5.1.3 Diagnostics
5.2 By Application - Global Rare Biomarkers Specimen Collection And Stabilization Revenue & Forecasts
5.2.1 By Application - Global Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2022
5.2.2 By Application - Global Rare Biomarkers Specimen Collection And Stabilization Revenue, 2023-2028
5.2.3 By Application - Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Rare Biomarkers Specimen Collection And Stabilization Market Size, 2021 & 2028
6.2 By Region - Global Rare Biomarkers Specimen Collection And Stabilization Revenue & Forecasts
6.2.1 By Region - Global Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2022
6.2.2 By Region - Global Rare Biomarkers Specimen Collection And Stabilization Revenue, 2023-2028
6.2.3 By Region - Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2028
6.3.2 US Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.3.3 Canada Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.3.4 Mexico Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2028
6.4.2 Germany Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.4.3 France Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.4.4 U.K. Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.4.5 Italy Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.4.6 Russia Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.4.7 Nordic Countries Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.4.8 Benelux Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2028
6.5.2 China Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.5.3 Japan Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.5.4 South Korea Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.5.5 Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.5.6 India Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2028
6.6.2 Brazil Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.6.3 Argentina Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2028
6.7.2 Turkey Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.7.3 Israel Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.7.4 Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
6.7.5 UAE Rare Biomarkers Specimen Collection And Stabilization Market Size, 2017-2028
7 Players Profiles
7.1 Miltenyi Biotec
7.1.1 Miltenyi Biotec Corporate Summary
7.1.2 Miltenyi Biotec Business Overview
7.1.3 Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.1.4 Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.1.5 Miltenyi Biotec Key News
7.2 QIAGEN
7.2.1 QIAGEN Corporate Summary
7.2.2 QIAGEN Business Overview
7.2.3 QIAGEN Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.2.4 QIAGEN Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.2.5 QIAGEN Key News
7.3 Creatv MicroTech
7.3.1 Creatv MicroTech Corporate Summary
7.3.2 Creatv MicroTech Business Overview
7.3.3 Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.3.4 Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.3.5 Creatv MicroTech Key News
7.4 Veridex
7.4.1 Veridex Corporate Summary
7.4.2 Veridex Business Overview
7.4.3 Veridex Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.4.4 Veridex Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.4.5 Veridex Key News
7.5 Creative-Bioarray
7.5.1 Creative-Bioarray Corporate Summary
7.5.2 Creative-Bioarray Business Overview
7.5.3 Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.5.4 Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.5.5 Creative-Bioarray Key News
7.6 Genetix
7.6.1 Genetix Corporate Summary
7.6.2 Genetix Business Overview
7.6.3 Genetix Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.6.4 Genetix Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.6.5 Genetix Key News
7.7 STRECK, INC.
7.7.1 STRECK, INC. Corporate Summary
7.7.2 STRECK, INC. Business Overview
7.7.3 STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.7.4 STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.7.5 STRECK, INC. Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.8.4 Roche Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.8.5 Roche Key News
7.9 Amgen
7.9.1 Amgen Corporate Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Rare Biomarkers Specimen Collection And Stabilization Major Product Offerings
7.9.4 Amgen Rare Biomarkers Specimen Collection And Stabilization Revenue in Global Market (2017-2022)
7.9.5 Amgen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rare Biomarkers Specimen Collection And Stabilization Market Opportunities & Trends in Global Market
Table 2. Rare Biomarkers Specimen Collection And Stabilization Market Drivers in Global Market
Table 3. Rare Biomarkers Specimen Collection And Stabilization Market Restraints in Global Market
Table 4. Key Players of Rare Biomarkers Specimen Collection And Stabilization in Global Market
Table 5. Top Rare Biomarkers Specimen Collection And Stabilization Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rare Biomarkers Specimen Collection And Stabilization Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rare Biomarkers Specimen Collection And Stabilization Product Type
Table 9. List of Global Tier 1 Rare Biomarkers Specimen Collection And Stabilization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rare Biomarkers Specimen Collection And Stabilization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rare Biomarkers Specimen Collection And Stabilization Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rare Biomarkers Specimen Collection And Stabilization Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rare Biomarkers Specimen Collection And Stabilization Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rare Biomarkers Specimen Collection And Stabilization Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2023-2028
Table 30. Miltenyi Biotec Corporate Summary
Table 31. Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 32. Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 33. QIAGEN Corporate Summary
Table 34. QIAGEN Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 35. QIAGEN Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 36. Creatv MicroTech Corporate Summary
Table 37. Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 38. Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 39. Veridex Corporate Summary
Table 40. Veridex Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 41. Veridex Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 42. Creative-Bioarray Corporate Summary
Table 43. Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 44. Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 45. Genetix Corporate Summary
Table 46. Genetix Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 47. Genetix Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 48. STRECK, INC. Corporate Summary
Table 49. STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 50. STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 53. Roche Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Rare Biomarkers Specimen Collection And Stabilization Product Offerings
Table 56. Amgen Rare Biomarkers Specimen Collection And Stabilization Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Rare Biomarkers Specimen Collection And Stabilization Segment by Type in 2021
Figure 2. Rare Biomarkers Specimen Collection And Stabilization Segment by Application in 2021
Figure 3. Global Rare Biomarkers Specimen Collection And Stabilization Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rare Biomarkers Specimen Collection And Stabilization Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rare Biomarkers Specimen Collection And Stabilization Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rare Biomarkers Specimen Collection And Stabilization Revenue in 2021
Figure 8. By Type - Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 12. US Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 16. Germany Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 17. France Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 24. China Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 28. India Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 30. Brazil Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share, 2017-2028
Figure 33. Turkey Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rare Biomarkers Specimen Collection And Stabilization Revenue, (US$, Mn), 2017-2028
Figure 37. Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. QIAGEN Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Veridex Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genetix Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Rare Biomarkers Specimen Collection And Stabilization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
